Skip to main content
Top
Published in: Journal of Inherited Metabolic Disease 3/2014

01-05-2014 | Rapid Communication

Human pyrroline-5-carboxylate reductase (PYCR1) acts on Δ1-piperideine-6-carboxylate generating L-pipecolic acid

Authors: Eduard A. Struys, Erwin E. W. Jansen, Gajja S. Salomons

Published in: Journal of Inherited Metabolic Disease | Issue 3/2014

Login to get access

Abstract

We have conducted biochemical studies with commercial available pyrroline-5-carboxylate (P5C) reductase (PYCR1) to investigate whether this enzyme plays a role in L-lysine degradation. Our recent studies with antiquitin/ALDH7A1 deficient fibroblasts revealed an alternative genesis of L-pipecolic acid, and we then hypothesized that PYCR1 was responsible for the conversion of Δ1-piperideine-6-carboxylate (P6C) into pipecolic acid. We here present evidence that PYCR1 is indeed able to produce L-pipecolic acid from P6C preparations, and the observed K m for this conversion is of the same magnitude as the K m described for the conversion of P5C to L-proline by PYCR1. Urine samples from antiquitin deficient individuals, who accumulate P6C, were also incubated with PYCR1 which resulted in a marked decrease of P6C and a huge increase of L-pipecolic acid as measured by LC-MS/MS, confirming that indeed PYCR1 generates L-pipecolic acid from P6C.
Literature
go back to reference Fujii T, Mukaihara M, Agematu H, Tsunekawa H (2002) Biotransformation of L-lysine to L-pipecolic acid catalyzed by L-lysine 6-aminotransferase and pyrroline-5-carboxylate reductase. Biosci Biotechnol Biochem 66:622–627PubMedCrossRef Fujii T, Mukaihara M, Agematu H, Tsunekawa H (2002) Biotransformation of L-lysine to L-pipecolic acid catalyzed by L-lysine 6-aminotransferase and pyrroline-5-carboxylate reductase. Biosci Biotechnol Biochem 66:622–627PubMedCrossRef
go back to reference Guernsey DL, Jiang H, Evans SC et al (2009) Mutation in pyrroline-5-carboxylate reductase 1 gene in families with cutis laxa type 2. Am J Hum Genet 85(1):120–129PubMedCentralPubMedCrossRef Guernsey DL, Jiang H, Evans SC et al (2009) Mutation in pyrroline-5-carboxylate reductase 1 gene in families with cutis laxa type 2. Am J Hum Genet 85(1):120–129PubMedCentralPubMedCrossRef
go back to reference Linster CL, Van Schaftingen E, Hanson AD (2013) Metabolite damage and its repair or pre-emption. Nat Chem Biol 9(2):72–80PubMedCrossRef Linster CL, Van Schaftingen E, Hanson AD (2013) Metabolite damage and its repair or pre-emption. Nat Chem Biol 9(2):72–80PubMedCrossRef
go back to reference Martinelli D, Häberle J, Rubio V et al (2012) Understanding pyrroline-5-carboxylate synthetase deficiency: clinical, molecular, functional, and expression studies, structure-based analysis, and novel therapy with arginine. J Inherit Metab Dis 35(5):761–776PubMedCrossRef Martinelli D, Häberle J, Rubio V et al (2012) Understanding pyrroline-5-carboxylate synthetase deficiency: clinical, molecular, functional, and expression studies, structure-based analysis, and novel therapy with arginine. J Inherit Metab Dis 35(5):761–776PubMedCrossRef
go back to reference Mills PB, Struys E, Jakobs C et al (2006) Mutations in antiquitin in individuals with pyridoxine-dependent seizures. Nat Med 12(3):307–309PubMedCrossRef Mills PB, Struys E, Jakobs C et al (2006) Mutations in antiquitin in individuals with pyridoxine-dependent seizures. Nat Med 12(3):307–309PubMedCrossRef
go back to reference Návarová H, Bernsdorff F, Döring AC, Zeier J (2012) Pipecolic acid, an endogenous mediator of defense amplification and priming, is a critical regulator of inducible plant immunity. Plant Cell 24(12):5123–5141PubMedCentralPubMedCrossRef Návarová H, Bernsdorff F, Döring AC, Zeier J (2012) Pipecolic acid, an endogenous mediator of defense amplification and priming, is a critical regulator of inducible plant immunity. Plant Cell 24(12):5123–5141PubMedCentralPubMedCrossRef
go back to reference Struys EA, Jakobs C (1999) Enantiomeric analysis of D- and L-pipecolic acid in plasma using a chiral capillary gas chromatography column and mass fragmentography. J Inherit Metab Dis 5:677–678CrossRef Struys EA, Jakobs C (1999) Enantiomeric analysis of D- and L-pipecolic acid in plasma using a chiral capillary gas chromatography column and mass fragmentography. J Inherit Metab Dis 5:677–678CrossRef
go back to reference Struys EA, Jakobs C (2007) Alpha-aminoadipic semialdehyde is the biomarker for pyridoxine dependent epilepsy caused by alpha-aminoadipic semialdehyde dehydrogenase deficiency. Mol Genet Metab 91(4):405PubMedCrossRef Struys EA, Jakobs C (2007) Alpha-aminoadipic semialdehyde is the biomarker for pyridoxine dependent epilepsy caused by alpha-aminoadipic semialdehyde dehydrogenase deficiency. Mol Genet Metab 91(4):405PubMedCrossRef
go back to reference Struys EA, Jakobs C (2010) Metabolism of lysine in alpha-aminoadipic semialdehyde dehydrogenase-deficient fibroblasts: evidence for an alternative pathway of pipecolic acid formation. FEBS Lett 584(1):181–186PubMedCrossRef Struys EA, Jakobs C (2010) Metabolism of lysine in alpha-aminoadipic semialdehyde dehydrogenase-deficient fibroblasts: evidence for an alternative pathway of pipecolic acid formation. FEBS Lett 584(1):181–186PubMedCrossRef
go back to reference Struys EA, Bok LA, Emal D, Houterman S, Willemsen MA (2012) Jakobs C (2012) The measurement of urinary Δ1-piperideine-6-carboxylate, the alter ego of α-aminoadipic semialdehyde, in antiquitin deficiency. J Inherit Metab Dis 35:909–916PubMedCentralPubMedCrossRef Struys EA, Bok LA, Emal D, Houterman S, Willemsen MA (2012) Jakobs C (2012) The measurement of urinary Δ1-piperideine-6-carboxylate, the alter ego of α-aminoadipic semialdehyde, in antiquitin deficiency. J Inherit Metab Dis 35:909–916PubMedCentralPubMedCrossRef
go back to reference Valle D, Downing SJ, Phang JM (1973) Proline inhibition of pyrroline-5-carboxylate reductase: differences in enzymes obtained from animal and tissue culture sources. Biochem Biophys Res Commun 54(4):1418–1424PubMedCrossRef Valle D, Downing SJ, Phang JM (1973) Proline inhibition of pyrroline-5-carboxylate reductase: differences in enzymes obtained from animal and tissue culture sources. Biochem Biophys Res Commun 54(4):1418–1424PubMedCrossRef
go back to reference Wanders RJ, Romeyn GJ, Schutgens RB, Tager JM (1989) L-pipecolate oxidase: a distinct peroxisomal enzyme in man. Biochem Biophys Res Commun 164(1):550–555PubMedCrossRef Wanders RJ, Romeyn GJ, Schutgens RB, Tager JM (1989) L-pipecolate oxidase: a distinct peroxisomal enzyme in man. Biochem Biophys Res Commun 164(1):550–555PubMedCrossRef
Metadata
Title
Human pyrroline-5-carboxylate reductase (PYCR1) acts on Δ1-piperideine-6-carboxylate generating L-pipecolic acid
Authors
Eduard A. Struys
Erwin E. W. Jansen
Gajja S. Salomons
Publication date
01-05-2014
Publisher
Springer Netherlands
Published in
Journal of Inherited Metabolic Disease / Issue 3/2014
Print ISSN: 0141-8955
Electronic ISSN: 1573-2665
DOI
https://doi.org/10.1007/s10545-013-9673-4

Other articles of this Issue 3/2014

Journal of Inherited Metabolic Disease 3/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine